Topiramate Tablet, Film Coated
Product Images NDC 68071-4877

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 68071-4877). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 4877 3)

Pdp (68071 4877 3)
This is a description of a Topiramate medication bottle containing 30 tablets of 100mg each. It shows the Manufacturer's National Drug Code (MFR), the National Drug Code (NDC) for the lot number, and the Expiration Date. The product is a white round pill with "ZD 14" on one side and "000000" on the other. The bottle warns to keep this product out of the reach of children and store it at controlled temperature between 68 to 77 degrees Fahrenheit. The label also recommends calling a doctor for any medical advice and reporting any side effects to FDA at 1-800-FDA-1088.*
FDA Label Image

Structured Product Formula For Topiramate (971eaaa1 517d 455f B883 46210de3be3d 01)

FDA Label Image

Structured Product Formula For Topiramate (971eaaa1 517d 455f B883 46210de3be3d 02)

Structured Product Formula For Topiramate (971eaaa1 517d 455f B883 46210de3be3d 02)
The text appears to be a caption or label for a graph displaying "Cumulative Rates for Time to First Seizure" using Kaplan Meier estimates. The graph compares the rates between two groups, one group taking topiramate at 50mg/day and the other group taking topiramate at 400mg/day. The x-axis indicates time in days with a range from 0 to 404.*
FDA Label Image

Topiramate Tablets Usp (971eaaa1 517d 455f B883 46210de3be3d 03)

Topiramate Tablets Usp (971eaaa1 517d 455f B883 46210de3be3d 03)
This is a table showing the reduction in migraine headache frequency from baseline to the double-blind phase in studies 10 and 11 for both adults and adolescents. The table includes data for the medication topiramate at three different dosages (0mg/day, 100mg/day, and 200mg/day) as well as a placebo group. There are also statistical significance levels provided for the differences in reduction rates between the groups.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.